Revenue Breakdown
Composition ()
No data
Revenue Streams
iSpecimen Inc (ISPC) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Specimens – contracts with customers, accounting for 89.9% of total sales, equivalent to $95.82K. Another important revenue stream is Shipping and other. Understanding this composition is critical for investors evaluating how ISPC navigates market cycles within the Software industry.
Profitability & Margins
Evaluating the bottom line, iSpecimen Inc maintains a gross margin of -92.05%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -2655.19%, while the net margin is -2608.68%. These profitability ratios, combined with a Return on Equity (ROE) of -296.20%, provide a clear picture of how effectively ISPC converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, ISPC competes directly with industry leaders such as XHLD and FCHL. With a market capitalization of $3.36M, it holds a significant position in the sector. When comparing efficiency, ISPC's gross margin of -92.05% stands against XHLD's 47.51% and FCHL's 28.49%. Such benchmarking helps identify whether iSpecimen Inc is trading at a premium or discount relative to its financial performance.
